$HCA

HCA takes $400M hit from rise in uninsured patients

HCA Healthcare reported a $400M hit from uninsured patients, reducing quarterly net income to $1.579B. Revenue rose 3.6%, with ER traffic up 5.1%. The company blames federal policy changes for the increase in uninsured patients and expects further losses from expiring tax credits, but plans to cut costs to offset them.

Original reporting
Published Oct 27, 2026, 2:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 3:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HCA takes $400M hit from rise in uninsured patients — source image
Decision brief

The 30-second read

$HCABearishMed
01

Why it matters

The earnings miss is likely to trigger a sell‑off in HCA shares and could pressure broader health‑care stocks.

02

Market read

The news presents a material earnings downside for a large‑cap health‑care company, suggesting near‑term negative price action.

03

What to watch

HCA's internal cost‑cutting programs and revenue growth in other segments may mitigate the earnings impact.

Relevance 8/10Novelty 8/10Timing: today

Background

HCA Healthcare disclosed a quarterly earnings shortfall caused by a $400M loss from uninsured patients, despite a 3.6% revenue increase.

Company-level read

Ticker impact

$HCABearishMedium confidence
Context

HCA reported a $400M hit to net income this quarter due to a rise in uninsured patients, reducing quarterly profit.

Expected impact

downward pressure as investors price in the earnings hit

Evidence & confidence

The disclosed $400M income reduction is material for a large‑cap hospital operator and is likely to weigh on the stock.

Market effects

U.S. healthcare stocks may face pressure as uninsured patient trends raise cost concerns.

U.S. equity markets could see a modest dip in hospital and health‑care sector indices.

Impact is largely confined to U.S. hospital operators with limited global spillover.

Counterpoint

The rise in uninsured patients could be a short‑term effect; long‑term growth and cost‑cutting initiatives may offset the hit.

Key entities

  • HCA Healthcare

    U.S. hospital operator reporting the earnings impact.

Related articles

$HCAMed

BofA raises HCA Healthcare stock price target on solid execution

BofA Securities raised its price target on HCA Healthcare (NYSE:HCA) to $500 from $450, citing solid execution and upside from supplemental Medicaid programs. The company's Q3 EBITDA exceeded estimates, with revenue of $19.85B and EPS of $7.22. HCA maintained its guidance range but faces near-term headwinds. The stock trades at an EV/EBITDA of 9.6x and a P/E ratio of 14.85.

$HCAMed

HCA Healthcare Inc (HCA) Q3 2026 Earnings Call Highlights: 22 Straight Quarters

HCA Healthcare (HCA) reported Q3 2026 earnings, highlighting a 19% decline in exchange equivalent admissions, a $400M unfavorable EBITDA impact, and reduced elective surgical volumes. The company expects $550M-$650M less in Medicaid supplemental payments in 2027. HCA anticipates 2027 earnings to be generally consistent with 2026, citing exchange headwinds and reduced supplemental payments.

$HCAMedAI 8/10

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call

HCA Healthcare reported $50M in incremental Medicaid benefits in Q3, raising its 2026 estimate to $600M-$800M. Costs were flat, but professional fees rose 12%. HCA reaffirmed 2026 guidance, expecting upper-half results. For 2027, it anticipates strong demand and earnings similar to 2026. The company spent $1.36B on capital expenditures, repurchased $3B in shares, and paid $165M in dividends.

$HCAHighAI 9/10

HCA (HCA) Q3 2026 Earnings Call Transcript

HCA Healthcare reported Q3 2026 revenue of $19.849 billion, up 3.6% YoY, with net income of $1.579 billion. EPS grew 4.4% to $7.27. Adjusted EBITDA rose 1.2% to $3.918 billion. Volume growth continued, but payer mix shifts impacted earnings. The company raised full-year revenue and EBITDA guidance. Management expects stable 2027 earnings despite Medicaid payment headwinds.

$HCAHighAI 8/10

HCA signals flat 2027 earnings as Medicaid payments drop; shares slide

HCA Healthcare forecasted flat 2027 earnings, citing lower Medicaid payments and rising uninsured patients, causing shares to drop over 5%. CEO Sam Hazen attributed the outlook to a fluid policy environment. Analysts expect 2027 EPS of $32.14, below the company's implied guidance. HCA's Q3 adjusted profit was $7.22 per share on revenue of $19.85 billion, beating estimates. The company expects 2026 EPS between $28.70 and $30.50 on revenue of $77.0B-$79.5B.

$HCAMedAI 8/10

HCA Healthcare, Inc. Q3 2026 Earnings Call Summary

HCA Healthcare reported Q3 2026 volume growth of 3%, driven by demand across various service lines. The company offset payer mix pressure through higher revenue per admission and improved contract collections. Elective surgical volumes faced challenges due to federal policy changes. HCA maintained flat same-facility costs despite inflation. The company anticipates 2027 earnings to be generally consistent with 2026, with 2% to 3% volume growth.